SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 4,323.00 |
| Enterprise Value ($M) | 3,949.03 |
| Book Value ($M) | 885.85 |
| Book Value / Share | 30.80 |
| Price / Book | 4.88 |
| NCAV ($M) | 491.85 |
| NCAV / Share | 17.10 |
| Price / NCAV | 8.79 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.06 |
| Return on Assets (ROA) | 0.06 |
| Return on Equity (ROE) | 0.07 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.36 |
| Current Ratio | 6.57 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 588.32 |
| Assets | 982.32 |
| Liabilities | 96.47 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Redmile Group, LLC | 2.80 | -53.25 | |
| 13G/A | Fmr Llc | 14.94 | 28.17 | |
| 13G | State Street Corp | 5.10 | ||
| 13G/A | Vanguard Group Inc | 10.05 | 17.79 | |
| 13G/A | BlackRock, Inc. | 13.80 | 118.17 | |
| 13G/A | Avoro Capital Advisors LLC | 9.10 | 81.95 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 85,584 | 370,080 | 23.13 | |
| 65,532 | 268,828 | 24.38 | |
| 75,493 | 426,989 | 17.68 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| KNSA – Kiniksa Pharmaceuticals, Ltd. | KPTI – Karyopharm Therapeutics Inc. |
| KRON – Kronos Bio, Inc. | KURA – Kura Oncology, Inc. |
| KYTX – Kyverna Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io